Quarter of people in England had poor NHS care in past year, report says
Survey for patient watchdog finds over half of those who made complaint were not satisfied with process or outcome
Related Articles
Ziftomenib Combined with Venetoclax/Azacitidine in Relapsed/Refractory NPM1-m or KMT2A-r Acute Myeloid Leukemia: Interim Phase 1a Results from KOMET‑007
Dr. Amer Zeidan presents interim Phase 1a results from the KOMET-007 trial, demonstrating the safety and robust clinical activity of ziftomenib combined with intensive chemotherapy…
A chance to be the Change
Hello, My name is Elias Hanna. I am a student at Saint Ignatius High School in Cleveland, with a deep desire to make a…
The Wannabe Fascists: A Guide to Understanding the Greatest Threat to Democracy
With , historian Federico Finchelstein offers a precise explanation of why Trumpism and similar movements across the world belong to a new political breed,…
For-profit health care might be damaging population health
Arguments have long raged about what role the private sector should play in the UK’s health system, where provision is dominated by the National Health…
Andreas Charalambous: Highlighting the importance of national cancer plans with ELLOK – OncoDaily
Andreas Charalambous: Highlighting the importance of national cancer plans with ELLOK / Andreas Charalambous, cancer, ELLOC, European Cancer Organisation,
The Fit Older Adult with Acute Myeloid Leukemia: Clinical Challenges to Providing Evidence-Based Frontline Treatment
Recent advances in acute myeloid leukemia (AML) come from studies investigating younger (age<60 years) adults or older (age≥75 years) or less fit adults
High-Sensitivity Troponin Assays Not All the Same, APACE Data Confirm
The ability to diagnose MI was better with troponin I, but T better predicted mortality. Both tests have strengths, researchers say.
A Healthcare Excellence Agenda for the New Administration | Posts | 8VC
Jan 27, 2025 – News – In 2023, the U.S. federal government spent a staggering $1.5 trillion on healthcare, yet Americans are becoming unhealthier by…
Validation of Patient-Reported Outcomes: A Low Bar
It used to be that if we wanted to assess a patient’s back pain, we would evaluate how far the patient could bend by measuring…
Access barriers to anti-CD19+ CART therapy for NHL across a community transplant and cellular therapy network
Key pointsForty-one percent of referrals in the community were unable to access anti-CD19+ CARTs for NHL between 2018 and 2022.Attrition from disease-relat
